These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 37500993)

  • 21. Malnutrition at diagnosis in amyotrophic lateral sclerosis (als) and its influence on survival: Using glim criteria.
    López-Gómez JJ; Ballesteros-Pomar MD; Torres-Torres B; De la Maza BP; Penacho-Lázaro MÁ; Palacio-Mures JM; Abreu-Padín C; López-Guzmán A; De Luis-Román DA
    Clin Nutr; 2021 Jan; 40(1):237-244. PubMed ID: 32507583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis.
    Desport JC; Preux PM; Magy L; Boirie Y; Vallat JM; Beaufrère B; Couratier P
    Am J Clin Nutr; 2001 Sep; 74(3):328-34. PubMed ID: 11522556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study.
    Deeb O; Nabulsi M
    Curr Top Med Chem; 2020; 20(26):2391-2403. PubMed ID: 32972341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors Affecting Energy Metabolism and Prognosis in Patients with Amyotrophic Lateral Sclerosis.
    Kurihara M; Bamba S; Yasuhara S; Itoh A; Nagao T; Nakanishi N; Nakamura R; Ogawa N; Kitamura A; Yamakawa I; Kim H; Sanada M; Urushitani M; Sasaki M
    Ann Nutr Metab; 2021; 77(4):236-243. PubMed ID: 34515052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic prediction by hypermetabolism varies depending on the nutritional status in early amyotrophic lateral sclerosis.
    Nakamura R; Kurihara M; Ogawa N; Kitamura A; Yamakawa I; Bamba S; Sanada M; Sasaki M; Urushitani M
    Sci Rep; 2021 Sep; 11(1):17943. PubMed ID: 34504168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compartment specific mitochondrial dysfunction in Drosophila knock-in model of ALS reversed by altered gene expression of OXPHOS subunits and pro-fission factor Drp1.
    Nemtsova Y; Steinert BL; Wharton KA
    Mol Cell Neurosci; 2023 Jun; 125():103834. PubMed ID: 36868541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis.
    Zhao J; Wang X; Huo Z; Chen Y; Liu J; Zhao Z; Meng F; Su Q; Bao W; Zhang L; Wen S; Wang X; Liu H; Zhou S
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis.
    Chang J; Shaw TB; Holdom CJ; McCombe PA; Henderson RD; Fripp J; Barth M; Guo CC; Ngo ST; Steyn FJ;
    Eur J Neurol; 2023 Jan; 30(1):57-68. PubMed ID: 36214080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal energy metabolism in ALS: a key player?
    Burg T; Van Den Bosch L
    Curr Opin Neurol; 2023 Aug; 36(4):338-345. PubMed ID: 37338894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative analysis of metabolomics and proteomics unravels purine metabolism dysregulation in the SOD1
    Xu X; Yang Q; Liu Z; Zhang R; Yu H; Wang M; Chen S; Xu G; Shao Y; Le W
    Neurobiol Dis; 2023 Jun; 181():106110. PubMed ID: 37001614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study protocol of RESCUE-ALS: A Phase 2,
    Vucic S; Kiernan MC; Menon P; Huynh W; Rynders A; Ho KS; Glanzman R; Hotchkin MT
    BMJ Open; 2021 Jan; 11(1):e041479. PubMed ID: 33431491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consideration of gravity as a possible etiological factor in amyotrophic lateral sclerosis.
    Akaishi T; Takahashi T; Abe M; Aoki M; Ishii T
    Med Hypotheses; 2019 Nov; 132():109369. PubMed ID: 31442918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights into the gene expression associated to amyotrophic lateral sclerosis.
    Recabarren-Leiva D; Alarcón M
    Life Sci; 2018 Jan; 193():110-123. PubMed ID: 29241710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments.
    Tefera TW; Borges K
    Front Neurosci; 2016; 10():611. PubMed ID: 28119559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Body mass index and dietary intervention: implications for prognosis of amyotrophic lateral sclerosis.
    Ngo ST; Steyn FJ; McCombe PA
    J Neurol Sci; 2014 May; 340(1-2):5-12. PubMed ID: 24629478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis.
    Sassani M; Alix JJ; McDermott CJ; Baster K; Hoggard N; Wild JM; Mortiboys HJ; Shaw PJ; Wilkinson ID; Jenkins TM
    Brain; 2020 Dec; 143(12):3603-3618. PubMed ID: 33439988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis.
    Jésus P; Fayemendy P; Nicol M; Lautrette G; Sourisseau H; Preux PM; Desport JC; Marin B; Couratier P
    Eur J Neurol; 2018 Jan; 25(1):97-104. PubMed ID: 28940704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis.
    Rué L; Oeckl P; Timmers M; Lenaerts A; van der Vos J; Smolders S; Poppe L; de Boer A; Van Den Bosch L; Van Damme P; Weishaupt JH; Ludolph AC; Otto M; Robberecht W; Lemmens R
    Acta Neuropathol Commun; 2019 Jul; 7(1):114. PubMed ID: 31300041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.
    Vercruysse P; Sinniger J; El Oussini H; Scekic-Zahirovic J; Dieterlé S; Dengler R; Meyer T; Zierz S; Kassubek J; Fischer W; Dreyhaupt J; Grehl T; Hermann A; Grosskreutz J; Witting A; Van Den Bosch L; Spreux-Varoquaux O; ; Ludolph AC; Dupuis L
    Brain; 2016 Apr; 139(Pt 4):1106-22. PubMed ID: 26984187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel hypothesis on metal dyshomeostasis and mitochondrial dysfunction in amyotrophic lateral sclerosis: Potential pathogenetic mechanism and therapeutic implications.
    Nakagawa Y; Yamada S
    Eur J Pharmacol; 2021 Feb; 892():173737. PubMed ID: 33220280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.